Alzheimer's affects tens of millions of people around the world and the goal of an effective treatment has been so elusive that it is seen as a 'black hole' for drugs spending. But now Andrew Ward and David Crow find fresh hope of a breakthrough

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.